SIONNA THERAPEUTICS, INC. Increase (Decrease) in Other Operating Assets
SIONNA THERAPEUTICS, INC. (SION) reported Increase (Decrease) in Other Operating Assets of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-03-02
- SIONNA THERAPEUTICS, INC. increase (decrease) in other operating assets for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- SIONNA THERAPEUTICS, INC. increase (decrease) in other operating assets for the quarter ending 2025-09-30 was $0.00.
- SIONNA THERAPEUTICS, INC. increase (decrease) in other operating assets for the quarter ending 2025-06-30 was $0.00.
- SIONNA THERAPEUTICS, INC. increase (decrease) in other operating assets for the quarter ending 2025-03-31 was $0.00.
- SIONNA THERAPEUTICS, INC. increase (decrease) in other operating assets for fiscal 2025 was $0.00.
- SIONNA THERAPEUTICS, INC. increase (decrease) in other operating assets for fiscal 2024 was -$35.00K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $0.00 derived: sum of 2 quarters · filed 2026-03-02 | $0.00 derived: sum of 3 quarters · filed 2026-03-02 | $0.00 10-K · filed 2026-03-02 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | $9.00K derived: sum of 4 quarters · filed 2026-03-02 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $0.00 10-Q · filed 2025-08-11 | $9.00K derived: sum of 3 quarters · filed 2026-03-02 | -$6.00K derived: sum of 4 quarters · filed 2026-03-02 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-12 | $9.00K derived: sum of 2 quarters · filed 2026-03-02 | -$6.00K derived: sum of 3 quarters · filed 2026-03-02 | -$20.00K derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$6.00K derived: sum of 2 quarters · filed 2026-03-02 | -$20.00K derived: sum of 3 quarters · filed 2026-03-02 | -$35.00K 10-K · filed 2026-03-02 |
| 2024-09-30 | -$15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$29.00K derived: sum of 2 quarters · filed 2025-11-05 | -$44.00K 10-Q · filed 2025-11-05 | |
| 2024-06-30 | -$14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$29.00K 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | -$15.00K 10-Q · filed 2025-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |